These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18480582

  • 1. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
    Nasu T, Kurisu S, Matsuno S, Tatsumi K, Kakimoto T, Kobayashi M, Nakano Y, Wakasaki H, Furuta H, Nishi M, Sasaki H, Suzuki H, Ito N, Fukumoto S, Nanjo K.
    Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
    [Abstract] [Full Text] [Related]

  • 2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N.
    BMC Musculoskelet Disord; 2017 Feb 13; 18(1):79. PubMed ID: 28193220
    [Abstract] [Full Text] [Related]

  • 3. Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
    Westerberg PA, Olauson H, Toss G, Wikström B, Morales O, Linde T, Jonsson K, Ljunggren O, Larsson TE.
    Endocr Pract; 2008 Apr 13; 14(3):362-7. PubMed ID: 18463045
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N, Shimizu Y, Suzuki H, Saito T, Okamoto T, Hori M, Akahane M, Fukumoto S, Fujita T.
    J Intern Med; 2010 Oct 13; 268(4):390-4. PubMed ID: 20698924
    [No Abstract] [Full Text] [Related]

  • 5. Tumor-induced Osteomalacia Caused by a Parotid Tumor.
    Takashi Y, Kinoshita Y, Ito N, Taguchi M, Takahashi M, Egami N, Tajima S, Nangaku M, Fukumoto S.
    Intern Med; 2017 Oct 13; 56(5):535-539. PubMed ID: 28250301
    [Abstract] [Full Text] [Related]

  • 6. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
    de Jongh RT, Vervloet MG, Bravenboer N, Heijboer AC, den Heijer M, Lips P.
    Ned Tijdschr Geneeskd; 2013 Oct 13; 157(28):A5908. PubMed ID: 23841927
    [Abstract] [Full Text] [Related]

  • 7. Tumor-induced osteomalacia: experience from a South American academic center.
    González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P, Contreras O, Villa A, Salech F, Toro L, Michea L, Florenzano P.
    Osteoporos Int; 2017 Jul 13; 28(7):2187-2193. PubMed ID: 28341900
    [Abstract] [Full Text] [Related]

  • 8. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y, Suzuki H, Ogura S, Imai R, Yamazaki Y, Yamashita T, Miyamoto Y, Okazaki H, Nakamura K, Nakahara K, Fukumoto S, Fujita T.
    J Clin Endocrinol Metab; 2004 Aug 13; 89(8):3979-82. PubMed ID: 15292336
    [Abstract] [Full Text] [Related]

  • 9. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar 13; 109(3):e57-63. PubMed ID: 20219587
    [Abstract] [Full Text] [Related]

  • 10. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y.
    Chin J Cancer; 2011 Nov 13; 30(11):794-804. PubMed ID: 22035861
    [Abstract] [Full Text] [Related]

  • 11. [Hypophosphatemic osteomalacia].
    Bullmann C, Benker G, Rosien U, Delling G, Siggelkow H, Schulte HM.
    Med Klin (Munich); 2008 Sep 15; 103(9):671-5. PubMed ID: 18813890
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S, Takeuchi Y, Nagano A, Fujita T.
    Bone; 1999 Sep 15; 25(3):375-7. PubMed ID: 10495143
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.
    Eur J Endocrinol; 2008 Feb 15; 158(2):265-71. PubMed ID: 18230836
    [Abstract] [Full Text] [Related]

  • 14. [Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor].
    Kin Y, Ogawa H, Matsumoto G, Mitsui S, Matsumoto T, Nishioka Y, Sakai S, Kimura K, Shimizu N, Hokka D, Tanaka Y, Maniwa Y.
    Kyobu Geka; 2019 Aug 15; 72(8):570-573. PubMed ID: 31353346
    [Abstract] [Full Text] [Related]

  • 15. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T.
    Proc Natl Acad Sci U S A; 2001 May 22; 98(11):6500-5. PubMed ID: 11344269
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
    Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ.
    J Clin Endocrinol Metab; 2006 Jun 22; 91(6):2055-61. PubMed ID: 16551733
    [Abstract] [Full Text] [Related]

  • 17. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T.
    Bone; 2008 Jun 22; 42(6):1235-9. PubMed ID: 18396126
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders.
    Takashi Y, Kawanami D, Fukumoto S.
    Curr Opin Endocrinol Diabetes Obes; 2024 Aug 01; 31(4):170-175. PubMed ID: 38687287
    [Abstract] [Full Text] [Related]

  • 19. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.
    Lin HA, Shih SR, Tseng YT, Chen CH, Chiu WY, Hsu CY, Tsai KS.
    J Clin Endocrinol Metab; 2014 Dec 01; 99(12):4403-7. PubMed ID: 25181387
    [Abstract] [Full Text] [Related]

  • 20. Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report.
    Oe Y, Kameda H, Nomoto H, Sakamoto K, Soyama T, Cho KY, Nakamura A, Iwasaki K, Abo D, Kudo K, Miyoshi H, Atsumi T.
    Medicine (Baltimore); 2021 Nov 19; 100(46):e27895. PubMed ID: 34797338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.